Overview
Formalized Training Cascades for Pharmacy Teams: Becoming an LGBTQ+ Ally to Improve HPV Immunization
Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.
Start Activity
Health disparities faced by LGBTQ+ individuals include social stigma and discrimination that are associated with increased rates of mental health disorders, substance abuse, and suicide. Better understanding the health and wellbeing of LGBTQ+ people throughout their lives has been prioritized in research of late; however, a paucity of HCPs who are culturally competent in LGBTQ+ healthcare threatens to undermine improvement efforts. Because pharmacists and pharmacy technicians provide accessible counseling and patient education, they are well positioned to be effective allies for LGBTQ+ individuals and bridge chasms in care. This includes improving HPV vaccination practices amongst gay and bisexual men, who have an increased prevalence of high-risk strains of HPV and elevated incidence of HPV-associated anal cancer. To support pharmacists and pharmacy technicians in becoming LGBTQ+ allies and mitigate risk of HPV associated cancers in high-risk populations, this training program, modeled from the CDC Training of Trainers, provides learners with the tools and resources they need.
This activity is intended for pharmacists and pharmacy technicians in the retail and community pharmacy setting.
LGBTQ+ (lesbian, gay, bisexual, trans, and queer) individuals face healthcare disparities due to lack of healthcare access stemming from discrimination and a lack of culturally competent providers. Further inequities spanning race, geography, or insurance coverage, undermine preventive health services such as human papillomavirus (HPV) vaccination in these individuals. HPV vaccination is safe and effective at preventing cancer-causing infections with evidence indicating that cervical cancer rates have decreased in the United States. However, increases in HPV-related oropharyngeal and anal/rectal cancers have been reported, particularly in men, underscoring the importance of HPV vaccination to eligible boys and men. Unfortunately, rates of vaccination continue to fall below national targets. Pharmacists and pharmacy technicians are well positioned to improve healthcare access and preventive care for LGBTQ+ patients given their proximity in community settings. Learners can follow expert recommendations for becoming an ally and creating a bridge to improved long-term outcomes for the LGBTQ+ community.
Upon completion of this activity, learners will be able to:
- Discuss the public health value of HPV vaccination to reduce the burden of HPV-related infections and cancers in high-risk patient populations
- Outline patient-, clinician-, and system-related facilitators and barriers of HPV vaccine acceptance, initiation, and completion among LGBTQ individuals
- Formulate pharmacy-led strategies to improve equitable and culturally competent HPV vaccination practices
HPV Burden
HPV Vaccination and Cancer Prevention
LGBTQ+ Discrimination and Healthcare Disparities
Reducing Barriers to Care and HPV Vaccination
Ensuring an Affirming Environment
Clinical Scenarios: Using Affirming Language Adult-learning Principles and Facilitation Skills
HPV Vaccination and Cancer Prevention
LGBTQ+ Discrimination and Healthcare Disparities
Reducing Barriers to Care and HPV Vaccination
Ensuring an Affirming Environment
Clinical Scenarios: Using Affirming Language Adult-learning Principles and Facilitation Skills
Provided by the Academy for Continued Healthcare Learning (ACHL).
Supported by an educational grant from Merck & Co., Inc.
1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker
Alex R. Mills, PharmD, BCACP, AAHIVP
Clinical Pharmacy Specialist
Community Health Network
Indianapolis, IN
Paul L. Reiter, PhD
Professor, Health Behavior and Health Promotion
The Ohio State University
Columbus, OH
Clinical Pharmacy Specialist
Community Health Network
Indianapolis, IN
Paul L. Reiter, PhD
Professor, Health Behavior and Health Promotion
The Ohio State University
Columbus, OH
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with all ineligible companies. All relevant financial relationships have been mitigated prior to this activity.
The following financial relationships have been provided:
Alex R. Mills, PharmD, BCACP, AAHIVP
No financial relationships to disclose
Paul L. Reiter, PhD
No financial relationships to disclose
The following financial relationships have been provided:
Alex R. Mills, PharmD, BCACP, AAHIVP
No financial relationships to disclose
Paul L. Reiter, PhD
No financial relationships to disclose
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
Discussion of scientific information on unapproved uses (SIUU), off-label, investigational, or experimental drug/device use: None
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
Discussion of scientific information on unapproved uses (SIUU), off-label, investigational, or experimental drug/device use: None
This activity will take approximately 90 minutes to complete. To receive credit, learners are required to complete the formative assessment questionnaire, view the online activity, and complete the posttest and evaluation. To receive credit, 80% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
Partial credit may not be awarded for CPE credit; participation in the complete activity is required to receive credit.
Partial credit may not be awarded for CPE credit; participation in the complete activity is required to receive credit.
The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This activity has been approved for 1.5 contact hours.
ACPE Universal Activity Number: 0396-0000-24-025-H06-P and 0396-0000-24-025-H06-T
Activity Type: Application
Release Date: December 13, 2024
Expiration Date: December 13, 2025
CPE credit will be submitted to CPE Monitor® on the first business day of each month.
